As TF-bearing EVs from endothelial cells may play an important role in cardiovascular disease further research is warranted in order to identify the mechanisms involved and to elucidate the role of procoagulant EVs as potential drug targets in various clinical conditions. The gene discussed is TF; the disease is cardiovascular disorder.